Radi by sme, aby ste sa stali súčasťou našej komunity. Pripojte sa k nášmu Discordu pre spojenie s nami a ostatnými členmi!

Ticker
QNTM

Price
35.00
Stock movement up
+4.82 (15.97%)
Company name
Quantum BioPharma Ltd.
Exchange
(NASDAQ
,
Currency
USD
)
Sector
Healthcare >
Biotechnology
Trhová kapitalizácia
133.59M
Hodnota ent
-
Cena/Predaje
-
Cena/Účtovná hodnota
-
Výnos dividend
-
Rast dividend
-
Roky rastu
-
Výplata FCF
-
Koncové P/E
-
Vyprojektované P/E
-
PEG
-
Rast EPS
-
1 ročná návratnosť
156.41%
3 ročná návratnosť
-13.60%
5 ročná návratnosť
-33.75%
10 ročná návratnosť
-
Naposledy aktualizované: 2025-08-27

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

DIVIDENDY

QNTM nevypláca dividendy alebo neboli prijaté žiadne údaje

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

VALUÁCIE

Pomery valuácie

Loading...
Údaje o pomeroch valuácie
Koncové P/E-
Cena k OCF-
Cena k FCF-
Cena k EBITDA-
EV k EBITDA-

Ocenenie (predaj/účtovná hodnota)

Loading...
Údaje o valuácii (predaj/účtovná hodnota).
Cena k Predajom-
Cena k účtovnej hodnote-
EV k Predajom-

FINANCIE

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

INFORMÁCIE O AKCIÁCH

Akciové grafy

Loading...
Údaje o cene akcií
Otvoriť34.88
Denné maximum38.25
Denné minimum31.91
Denný objem826K
Historické maximum9080.17
1 ročný odhad analytikov169.00
Beta1.62
EPS (TTM)-
Dividenda na akciu-
Dátum ex-div-
Ďalší dátum zárobkov-

Potenciál poklesu ceny

Loading...
Údaje o potenciáli poklesu ceny
QNTMS&P500
Aktuálny pokles ceny proti historickému maximu-99.61%-3.04%
Najvyšší pokles ceny-99.97%-56.47%
Dátum najvyššieho poklesu27 Jan 20259 Mar 2009
Priemerný pokles z maxima-90.99%-11.04%
Priemerný čas k novému maximumu104 days12 days
Maximálny čas k novému maximumu1695 days1805 days

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

PODROBNOSTI O SPOLOČNOSTI
QNTM (Quantum BioPharma Ltd.) company logo
Trhová kapitalizácia
133.59M
Kategória trhovej kapitalizácie
Small-cap
Popis
Quantum BioPharma Ltd., together with its subsidiaries, operates as a biopharmaceutical company. It operates through two segments, Biopharmaceutical Innovation and Strategic Investments. The company researches and develops a portfolio of assets and biotech solutions for the treatment of neurodegenerative, inflammatory and metabolic disorders, and alcohol misuse disorders with drug candidates in different stages of development. Its lead compound is Lucid-MS, a patented new chemical entity that is in Phase 2 clinical trial to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis, in preclinical models. It also develops FSD-PEA, which is in preparation for Phase 2 trial for the treatment of inflammatory diseases, such as mast cell activation syndrome; Lucid-PSYCH to treat major depressive disorder; and unbuzzd, a dietary supplement for the treatment of alcohol misuse. In addition, the company maintains a portfolio of strategic investments comprising loans secured by residential property. The company was formerly known as FSD Pharma Inc. and changed its name to Quantum BioPharma Ltd., in August 2024. Quantum BioPharma Ltd. was founded in 1998 and is headquartered in Toronto, Canada.
Zamestnanci
0
Vzťahy s investormi
-
SEC podania
CEO
Krajina
USA
Mesto
Typ akcie
-
CCC status
-
Dividendová frekvencia
-
PODUJATIA A PREZENTÁCIE
UdalostiPrezentácie
Loading...

iO Charts is a Seeking Alpha partner

POROZUMIEŤ PODNIKU
Loading...